Cargando…
A comprehensive individual patient data meta‐analysis of the effects of cardiac contractility modulation on functional capacity and heart failure‐related quality of life
AIMS: Cardiac contractility modulation, also referred to as CCM™, has emerged as a promising device treatment for heart failure (HF) in patients not indicated for cardiac resynchronization therapy. We performed a comprehensive individual patient data meta‐analysis of all non‐confounded prospective r...
Autores principales: | Giallauria, Francesco, Cuomo, Gianluigi, Parlato, Alessandro, Raval, Nirav Y., Kuschyk, Jürgen, Stewart Coats, Andrew JS |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524137/ https://www.ncbi.nlm.nih.gov/pubmed/32700809 http://dx.doi.org/10.1002/ehf2.12902 |
Ejemplares similares
-
Individual patient data meta‐analysis of the effects of the CARILLON® mitral contour system
por: Giallauria, Francesco, et al.
Publicado: (2020) -
Septal myocardial scar burden predicts the response to cardiac contractility modulation in patients with heart failure
por: Ansari, Uzair, et al.
Publicado: (2022) -
Clinical Evidence for Q10 Coenzyme Supplementation in Heart Failure: From Energetics to Functional Improvement
por: Di Lorenzo, Anna, et al.
Publicado: (2020) -
Long‐term results of combined cardiac contractility modulation and subcutaneous defibrillator therapy in patients with heart failure and reduced ejection fraction
por: Röger, Susanne, et al.
Publicado: (2018) -
Effects of Sacubitril/Valsartan on Exercise Capacity in Patients with Heart Failure with Reduced Ejection Fraction and the Role of Percentage of Delayed Enhancement Measured by Cardiac Magnetic Resonance in Predicting Therapeutic Response: A Multicentre Study
por: Nugara, Cinzia, et al.
Publicado: (2023)